Lung Cancer
Conference Coverage
Recent quitters win big in lung screening trials
Key clinical point: Quitting smoking results in a significant reduction in all-cause mortality among heavy smokers taking part in screening...
News
SWITCH 1 supports carboplatin-vinorelbine regimen in early NSCLC
An adjuvant regimen of carboplatin plus vinorelbine is well tolerated and efficacious in patients who have undergone complete resection of early...
News
Vaccines targeting MUC1 show activity against NSCLC
Key clinical point: Therapeutic vaccines targeting MUC1 show clinical activity against non–small cell lung cancer. Major finding: Overall survival...
Conference Coverage
MAPS: Bevacizumab prolongs survival in mesothelioma
Key clinical point: Adding bevacizumab to pemetrexed and cisplatin prolonged overall survival by almost 3 months. Major finding: Median overall...
Article
Lung adenocarcinomas: mutations you don’t want to miss
Conference Coverage
Clinical advances drive lung cancer staging, classification changes
Key clinical point: Improved understanding of lung cancer over the last decade has prompted updates to international tumor staging and...
News
New cancer cases to reach nearly 2.4 million in 2035 – AACR
News
Nivolumab benefits heavily pretreated squamous NSCLC patients
Key clinical point: Nivolumab was associated with improved survival among patients with heavily pretreated squamous cell NSCLC. Major finding: 1-...
News
CHEST Fellow Receives ASTRO Honor
News
Chemotherapy plus cetuximab shows OS benefit in squamous NSCLC
Key clinical point:Adding cetuximab to chemotherapy improved overall survival in patients with squamous cell non–small cell lung cancer with high...